X

Vous n'êtes pas connecté

Rubriques :

  - MOUNTAINTODAY.IN - A La Une - 11/07/2024 18:48

Hypertension Pipeline 2024 | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Ionis Pharmaceuticals, Future Medicine, Pharmosa BioPharm, Aerovate Therapeutics, Novartis,

DelveInsight, “Hypertension Pipeline Insight 2024” report provides comprehensive insights about 100+ Hypertension companies and 100+ pipeline drugs in Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical

Articles similaires

Sorry! Image not available at this time

Autism Spectrum Disorder Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism ...

wn.com - 07/Jul 11:40

"Autism Spectrum Disorder Clinical Trials" Autism spectrum disorder companies, such as Astrogen, MapLight Therapeutics, Axial Therapeutics, Aardvark...

Sorry! Image not available at this time

Autism Spectrum Disorder Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism ...

wn.com - 07/Jul 11:40

"Autism Spectrum Disorder Clinical Trials" Autism spectrum disorder companies, such as Astrogen, MapLight Therapeutics, Axial Therapeutics, Aardvark...

Sorry! Image not available at this time

Sickle Cell Disease Drugs Market 2034: Clinical Trials, Prevalence, EMA, PDMA, FDA Approvals, Medication, Statistics, ...

wn.com - 07/Jul 12:33

"Sickle Cell Disease Drugs Market" Sickle Cell Disease companies working in the treatment market are Cellectis, Sana Biotechnology, Global Blood...

Sorry! Image not available at this time

Sickle Cell Disease Drugs Market 2034: Clinical Trials, Prevalence, EMA, PDMA, FDA Approvals, Medication, Statistics, ...

wn.com - 07/Jul 12:33

"Sickle Cell Disease Drugs Market" Sickle Cell Disease companies working in the treatment market are Cellectis, Sana Biotechnology, Global Blood...

Sorry! Image not available at this time

Paroxysmal Nocturnal Hemoglobinuria Treatment Market Set for Robust Growth Through 2034, Driven by Advancing Clinical ...

wn.com - 11/Jul 01:34

The Paroxysmal Nocturnal Hemoglobinuria treatment market is experiencing significant expansion, driven by increasing disease awareness, rising...

Sorry! Image not available at this time

IgA Nephropathy Therapeutic Market Expected to Witness Significant Growth By 2034, Driven by Recent FDA ...

wn.com - 03/Jul 00:55

"IgA Nephropathy Market Insight, Epidemiology And Market Forecast - 2034" The IgA Nephropathy (IgAN) treatment market is poised for substantial...

Sorry! Image not available at this time

IgA Nephropathy Therapeutic Market Expected to Witness Significant Growth By 2034, Driven by Recent FDA ...

wn.com - 03/Jul 00:55

"IgA Nephropathy Market Insight, Epidemiology And Market Forecast - 2034" The IgA Nephropathy (IgAN) treatment market is poised for substantial...

Sorry! Image not available at this time

Vitiligo Treatment Innovation Accelerates with JAK Inhibitors and Novel Immunotherapies | DelveInsight

wn.com - 11/Jul 01:34

"Vitiligo Pipeline Insight, 2025" Leading companies, such as Incyte Corporation, TWi Biotechnology, Amgen, Pfizer, Arcutis Biotherapeutics,...

Sorry! Image not available at this time

Vitiligo Treatment Innovation Accelerates with JAK Inhibitors and Novel Immunotherapies | DelveInsight

wn.com - 11/Jul 01:34

"Vitiligo Pipeline Insight, 2025" Leading companies, such as Incyte Corporation, TWi Biotechnology, Amgen, Pfizer, Arcutis Biotherapeutics,...

Sorry! Image not available at this time

PI3K Inhibitor Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | ...

wn.com - 10/Jul 16:31

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PI3K Inhibitor pipeline constitutes 20+ key companies continuously...

Les derniers communiqués